{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:52:13Z","timestamp":1790617933697,"version":"4.1.0"},"reference-count":12,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100001116","name":"Foundation Fighting Blindness Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001116","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["canadianjournalofophthalmology.ca","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Ophthalmology"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.jcjo.2021.02.007","type":"journal-article","created":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T16:14:45Z","timestamp":1615565685000},"page":"16-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Pentosan polysulfate maculopathy versus age-related macular degeneration: comparative assessment with multimodal imaging"],"prefix":"10.1016","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2080-9179","authenticated-orcid":false,"given":"Joseph S.","family":"Christiansen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1985-2479","authenticated-orcid":false,"given":"Alexander C.","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duncan E.","family":"Berry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2218-6611","authenticated-orcid":false,"given":"Nieraj","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcjo.2021.02.007_bib0001","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.juro.2018.02.011","article-title":"FDA BRUDAC 2018 criteria for interstitial cystitis\/bladder pain syndrome clinical trials: future direction for research","volume":"200","author":"Nickel","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.jcjo.2021.02.007_bib0002","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/j.ophtha.2018.04.026","article-title":"Pigmentary maculopathy associated with chronic exposure to pentosan polysulfate sodium","volume":"125","author":"Pearce","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2021.02.007_bib0003","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1001\/jamaophthalmol.2019.3392","article-title":"Phenotypic spectrum of pentosan polysulfate sodium-associated maculopathy: a multicenter study","volume":"137","author":"Hanif","year":"2019","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.jcjo.2021.02.007_bib0004","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.ophtha.2019.04.024","article-title":"Strength of association between pentosan polysulfate and a novel maculopathy","volume":"126","author":"Hanif","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2021.02.007_bib0005","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1136\/bjophthalmol-2019-314765","article-title":"Association of macular disease with long-term use of pentosan polysulfate sodium: findings from a US cohort","volume":"104","author":"Jain","year":"2020","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jcjo.2021.02.007_bib0006","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jcjo.2019.12.001","article-title":"Pentosan-associated maculopathy: prevalence, screening guidelines, and spectrum of findings based on prospective multimodal analysis","volume":"55","author":"Wang","year":"2020","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.jcjo.2021.02.007_bib0007","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.ophtha.2020.01.017","article-title":"Prevalence of maculopathy associated with long-term pentosan polysulfate therapy","volume":"127","author":"Vora","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2021.02.007_bib0008","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1001\/archopht.122.4.564","article-title":"Prevalence of age-related macular degeneration in the United States","volume":"122","author":"Friedman","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jcjo.2021.02.007_bib0009","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1001\/archopht.119.10.1417","article-title":"A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS Report No. 8","volume":"119","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jcjo.2021.02.007_bib0010","doi-asserted-by":"crossref","first-page":"P1","DOI":"10.1016\/j.ophtha.2019.09.024","article-title":"Age-related macular degeneration preferred practice pattern","volume":"127","author":"Flaxel","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2021.02.007_bib0011","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1097\/IAE.0b013e3181ee5ce8","article-title":"Drusen characterization with multimodal imaging","volume":"30","author":"Spaide","year":"2010","journal-title":"Retina"},{"key":"10.1016\/j.jcjo.2021.02.007_bib0012","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1097\/IAE.0000000000000870","article-title":"Comparison of manual and semiautomated fundus autofluorescence analysis of macular atrophy in Stargardt disease phenotype","volume":"36","author":"Kuehlewein","year":"2016","journal-title":"Retina"}],"container-title":["Canadian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418221000442?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418221000442?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T20:10:13Z","timestamp":1757794213000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008418221000442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S0008418221000442"],"URL":"https:\/\/doi.org\/10.1016\/j.jcjo.2021.02.007","relation":{},"ISSN":["0008-4182"],"issn-type":[{"value":"0008-4182","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pentosan polysulfate maculopathy versus age-related macular degeneration: comparative assessment with multimodal imaging","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcjo.2021.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Canadian Ophthalmological Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}